Matthew Keller
Concepts (499)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 44 | 2025 | 1406 | 4.680 |
Why?
| | Polymorphism, Single Nucleotide | 55 | 2026 | 2145 | 4.600 |
Why?
| | Biological Specimen Banks | 7 | 2025 | 102 | 3.950 |
Why?
| | Models, Genetic | 23 | 2025 | 536 | 3.050 |
Why?
| | Multifactorial Inheritance | 17 | 2025 | 202 | 3.000 |
Why?
| | Schizophrenia | 16 | 2022 | 446 | 2.890 |
Why?
| | Genetic Predisposition to Disease | 35 | 2025 | 2363 | 2.770 |
Why?
| | Gene-Environment Interaction | 9 | 2021 | 180 | 1.880 |
Why?
| | Dermatology | 5 | 2025 | 128 | 1.840 |
Why?
| | Homozygote | 11 | 2023 | 199 | 1.760 |
Why?
| | Genome, Human | 13 | 2021 | 422 | 1.680 |
Why?
| | Genetics, Population | 5 | 2022 | 214 | 1.630 |
Why?
| | Phenotype | 32 | 2025 | 3162 | 1.600 |
Why?
| | Genetic Variation | 19 | 2022 | 983 | 1.520 |
Why?
| | Paternal Inheritance | 2 | 2021 | 3 | 1.340 |
Why?
| | Maternal Inheritance | 2 | 2021 | 15 | 1.340 |
Why?
| | Statistics as Topic | 3 | 2021 | 284 | 1.330 |
Why?
| | Consanguinity | 4 | 2018 | 49 | 1.190 |
Why?
| | Genomics | 10 | 2026 | 834 | 1.180 |
Why?
| | United Kingdom | 9 | 2025 | 338 | 1.110 |
Why?
| | Twins | 5 | 2021 | 156 | 1.100 |
Why?
| | Quantitative Trait, Heritable | 8 | 2025 | 118 | 1.100 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 824 | 1.070 |
Why?
| | Family | 7 | 2024 | 679 | 1.070 |
Why?
| | Mental Disorders | 12 | 2022 | 1168 | 1.070 |
Why?
| | Humans | 150 | 2026 | 144759 | 1.070 |
Why?
| | Twins, Dizygotic | 6 | 2013 | 109 | 1.060 |
Why?
| | Linkage Disequilibrium | 7 | 2026 | 246 | 1.030 |
Why?
| | Family Characteristics | 2 | 2025 | 197 | 1.020 |
Why?
| | Marriage | 3 | 2025 | 122 | 0.980 |
Why?
| | Genome | 3 | 2018 | 306 | 0.980 |
Why?
| | Twins, Monozygotic | 5 | 2013 | 134 | 0.960 |
Why?
| | Academic Success | 2 | 2023 | 31 | 0.960 |
Why?
| | Cognition | 15 | 2022 | 1266 | 0.930 |
Why?
| | Chromosomes | 1 | 2026 | 108 | 0.920 |
Why?
| | Reproduction | 4 | 2022 | 207 | 0.910 |
Why?
| | Smoking | 7 | 2025 | 1472 | 0.910 |
Why?
| | Family Health | 2 | 2024 | 191 | 0.880 |
Why?
| | Haplotypes | 5 | 2026 | 490 | 0.880 |
Why?
| | Software | 3 | 2017 | 690 | 0.870 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 153 | 0.860 |
Why?
| | Environment | 5 | 2017 | 305 | 0.850 |
Why?
| | Spouses | 1 | 2025 | 108 | 0.820 |
Why?
| | Communication Barriers | 2 | 2016 | 124 | 0.810 |
Why?
| | Sexual Partners | 1 | 2025 | 192 | 0.800 |
Why?
| | Informed Consent | 2 | 2016 | 198 | 0.800 |
Why?
| | Genotype | 13 | 2021 | 1833 | 0.790 |
Why?
| | Genetics, Behavioral | 2 | 2020 | 17 | 0.790 |
Why?
| | Depression | 4 | 2022 | 1558 | 0.790 |
Why?
| | Body Height | 6 | 2025 | 202 | 0.750 |
Why?
| | Algorithms | 4 | 2026 | 1837 | 0.750 |
Why?
| | Biological Evolution | 4 | 2018 | 488 | 0.740 |
Why?
| | Intelligence | 6 | 2025 | 112 | 0.730 |
Why?
| | Mentors | 2 | 2025 | 219 | 0.730 |
Why?
| | Female | 79 | 2026 | 78271 | 0.700 |
Why?
| | Tobacco Use Disorder | 3 | 2025 | 218 | 0.700 |
Why?
| | Pedigree | 5 | 2024 | 514 | 0.670 |
Why?
| | Educational Status | 8 | 2024 | 467 | 0.660 |
Why?
| | Male | 67 | 2026 | 72315 | 0.650 |
Why?
| | Computer Simulation | 7 | 2022 | 1025 | 0.650 |
Why?
| | Inbreeding Depression | 2 | 2021 | 3 | 0.640 |
Why?
| | Research Design | 6 | 2018 | 1135 | 0.610 |
Why?
| | Adult | 51 | 2026 | 40449 | 0.600 |
Why?
| | Alleles | 10 | 2024 | 879 | 0.600 |
Why?
| | Twin Studies as Topic | 3 | 2018 | 14 | 0.600 |
Why?
| | Wearable Electronic Devices | 3 | 2025 | 63 | 0.600 |
Why?
| | Bias | 5 | 2022 | 202 | 0.600 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 675 | 0.560 |
Why?
| | Cervical Length Measurement | 1 | 2018 | 4 | 0.560 |
Why?
| | Alcoholism | 6 | 2025 | 817 | 0.560 |
Why?
| | Hyperhidrosis | 1 | 2018 | 7 | 0.550 |
Why?
| | Fees and Charges | 1 | 2018 | 11 | 0.550 |
Why?
| | Psychological Trauma | 1 | 2019 | 57 | 0.550 |
Why?
| | Botulinum Toxins | 1 | 2018 | 46 | 0.530 |
Why?
| | Tympanoplasty | 1 | 2017 | 9 | 0.520 |
Why?
| | Tympanic Membrane Perforation | 1 | 2017 | 17 | 0.520 |
Why?
| | Auditory Threshold | 1 | 2017 | 51 | 0.510 |
Why?
| | Socioeconomic Factors | 3 | 2019 | 1326 | 0.510 |
Why?
| | Beauty | 2 | 2013 | 19 | 0.500 |
Why?
| | Blast Injuries | 1 | 2017 | 63 | 0.500 |
Why?
| | Drug Eruptions | 1 | 2016 | 28 | 0.490 |
Why?
| | Third-Party Consent | 1 | 2016 | 21 | 0.490 |
Why?
| | Erlotinib Hydrochloride | 1 | 2016 | 72 | 0.490 |
Why?
| | Proxy | 1 | 2016 | 34 | 0.490 |
Why?
| | Psychotic Disorders | 2 | 2016 | 186 | 0.480 |
Why?
| | Skin Neoplasms | 2 | 2014 | 847 | 0.480 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 570 | 0.470 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 885 | 0.460 |
Why?
| | Genetic Loci | 9 | 2022 | 261 | 0.460 |
Why?
| | Chromosome Mapping | 4 | 2026 | 510 | 0.460 |
Why?
| | Creativity | 1 | 2015 | 17 | 0.450 |
Why?
| | Internship and Residency | 2 | 2025 | 1257 | 0.450 |
Why?
| | Nootropic Agents | 3 | 2021 | 30 | 0.440 |
Why?
| | Physician-Patient Relations | 3 | 2016 | 585 | 0.440 |
Why?
| | Body Mass Index | 5 | 2024 | 2438 | 0.430 |
Why?
| | Likelihood Functions | 5 | 2022 | 143 | 0.420 |
Why?
| | Parkinson Disease | 3 | 2025 | 600 | 0.410 |
Why?
| | Quantitative Trait Loci | 4 | 2024 | 374 | 0.410 |
Why?
| | Genealogy and Heraldry | 1 | 2013 | 3 | 0.400 |
Why?
| | Nevus, Pigmented | 1 | 2014 | 35 | 0.400 |
Why?
| | Deglutition Disorders | 2 | 2025 | 147 | 0.400 |
Why?
| | Middle Aged | 34 | 2026 | 35875 | 0.400 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 132 | 0.390 |
Why?
| | Genetic Pleiotropy | 1 | 2013 | 32 | 0.390 |
Why?
| | Depressive Disorder | 2 | 2007 | 387 | 0.390 |
Why?
| | Bipolar Disorder | 2 | 2015 | 280 | 0.380 |
Why?
| | Medication Therapy Management | 1 | 2013 | 73 | 0.380 |
Why?
| | Telemedicine | 1 | 2022 | 945 | 0.380 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 187 | 0.380 |
Why?
| | Fluorouracil | 1 | 2013 | 235 | 0.370 |
Why?
| | Affect | 2 | 2005 | 318 | 0.370 |
Why?
| | Dementia | 1 | 2016 | 303 | 0.370 |
Why?
| | Marijuana Abuse | 1 | 2015 | 211 | 0.360 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.360 |
Why?
| | Inbreeding | 1 | 2011 | 20 | 0.350 |
Why?
| | Gene Frequency | 6 | 2022 | 481 | 0.350 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 318 | 0.340 |
Why?
| | Sex Characteristics | 2 | 2013 | 790 | 0.340 |
Why?
| | Young Adult | 20 | 2026 | 14105 | 0.330 |
Why?
| | Social Environment | 4 | 2019 | 254 | 0.320 |
Why?
| | Genetic Markers | 3 | 2020 | 331 | 0.320 |
Why?
| | Risk Factors | 14 | 2025 | 10779 | 0.320 |
Why?
| | Adaptation, Psychological | 3 | 2022 | 717 | 0.320 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 102 | 0.310 |
Why?
| | Substance-Related Disorders | 5 | 2025 | 1094 | 0.310 |
Why?
| | Bariatric Surgery | 2 | 2024 | 242 | 0.310 |
Why?
| | Live Birth | 2 | 2020 | 68 | 0.310 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2009 | 28 | 0.300 |
Why?
| | Aged | 18 | 2026 | 25913 | 0.300 |
Why?
| | Uniparental Disomy | 1 | 2009 | 9 | 0.300 |
Why?
| | Negative-Pressure Wound Therapy | 2 | 2020 | 28 | 0.300 |
Why?
| | Models, Statistical | 5 | 2018 | 681 | 0.300 |
Why?
| | Life Change Events | 2 | 2007 | 147 | 0.300 |
Why?
| | Fathers | 1 | 2009 | 51 | 0.290 |
Why?
| | Stillbirth | 2 | 2019 | 77 | 0.290 |
Why?
| | Personality | 2 | 2012 | 132 | 0.290 |
Why?
| | Models, Theoretical | 3 | 2021 | 582 | 0.280 |
Why?
| | Dysphonia | 2 | 2018 | 13 | 0.280 |
Why?
| | Retrospective Studies | 18 | 2026 | 17066 | 0.280 |
Why?
| | Psychiatry | 1 | 2011 | 193 | 0.280 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2025 | 232 | 0.280 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 641 | 0.280 |
Why?
| | Laryngeal Diseases | 2 | 2018 | 31 | 0.280 |
Why?
| | Evolution, Molecular | 2 | 2017 | 514 | 0.280 |
Why?
| | Mendelian Randomization Analysis | 3 | 2024 | 55 | 0.270 |
Why?
| | Registries | 2 | 2015 | 2385 | 0.270 |
Why?
| | Adolescent | 27 | 2026 | 22428 | 0.270 |
Why?
| | Psoriasis | 2 | 2021 | 112 | 0.270 |
Why?
| | Genetic Association Studies | 4 | 2019 | 372 | 0.270 |
Why?
| | Inheritance Patterns | 4 | 2021 | 44 | 0.270 |
Why?
| | Parent-Child Relations | 2 | 2021 | 270 | 0.270 |
Why?
| | Inappropriate Prescribing | 2 | 2026 | 63 | 0.260 |
Why?
| | Myeloproliferative Disorders | 2 | 2019 | 19 | 0.260 |
Why?
| | Chromosomes, Human | 3 | 2018 | 41 | 0.260 |
Why?
| | Computational Biology | 1 | 2011 | 680 | 0.250 |
Why?
| | Pediatric Obesity | 2 | 2024 | 637 | 0.240 |
Why?
| | Facial Injuries | 1 | 2026 | 24 | 0.240 |
Why?
| | Practice Patterns, Physicians' | 2 | 2021 | 1356 | 0.230 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3409 | 0.230 |
Why?
| | Pregnancy | 7 | 2025 | 7190 | 0.230 |
Why?
| | Selection, Genetic | 2 | 2012 | 256 | 0.230 |
Why?
| | Neurodevelopmental Disorders | 2 | 2019 | 227 | 0.220 |
Why?
| | Weather | 1 | 2005 | 43 | 0.220 |
Why?
| | Surveys and Questionnaires | 6 | 2025 | 6048 | 0.220 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2194 | 0.220 |
Why?
| | Positive-Pressure Respiration | 1 | 2026 | 112 | 0.220 |
Why?
| | Biofeedback, Psychology | 1 | 2025 | 35 | 0.220 |
Why?
| | Executive Function | 2 | 2022 | 461 | 0.220 |
Why?
| | Noninvasive Ventilation | 1 | 2026 | 62 | 0.220 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2025 | 63 | 0.220 |
Why?
| | Needs Assessment | 2 | 2020 | 404 | 0.210 |
Why?
| | Recombination, Genetic | 2 | 2016 | 205 | 0.200 |
Why?
| | Apolipoproteins E | 1 | 2024 | 94 | 0.200 |
Why?
| | Pregnancy Complications | 2 | 2019 | 592 | 0.200 |
Why?
| | Alcohol Drinking | 2 | 2022 | 826 | 0.200 |
Why?
| | Cognition Disorders | 2 | 2019 | 538 | 0.190 |
Why?
| | Tobacco Products | 1 | 2024 | 84 | 0.190 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 11 | 0.190 |
Why?
| | Ureteral Calculi | 1 | 2022 | 16 | 0.190 |
Why?
| | Parents | 2 | 2022 | 1403 | 0.190 |
Why?
| | Population Health | 1 | 2023 | 44 | 0.190 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2022 | 44 | 0.180 |
Why?
| | Lithotripsy | 1 | 2022 | 49 | 0.180 |
Why?
| | Face | 2 | 2013 | 173 | 0.180 |
Why?
| | Birth Weight | 1 | 2025 | 522 | 0.180 |
Why?
| | Receptors, Nicotinic | 2 | 2025 | 321 | 0.180 |
Why?
| | Tobacco Use | 1 | 2022 | 61 | 0.180 |
Why?
| | Internationality | 1 | 2022 | 156 | 0.180 |
Why?
| | Fractures, Open | 1 | 2022 | 29 | 0.180 |
Why?
| | Faculty, Medical | 1 | 2025 | 302 | 0.180 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 428 | 0.180 |
Why?
| | Compartment Syndromes | 1 | 2022 | 36 | 0.180 |
Why?
| | Health Care Costs | 2 | 2022 | 427 | 0.180 |
Why?
| | Mutation, Missense | 2 | 2019 | 340 | 0.170 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 15 | 0.170 |
Why?
| | Respiratory Rate | 1 | 2021 | 23 | 0.170 |
Why?
| | Tibial Fractures | 1 | 2022 | 72 | 0.170 |
Why?
| | Wireless Technology | 1 | 2021 | 18 | 0.170 |
Why?
| | Gastric Bypass | 1 | 2022 | 125 | 0.170 |
Why?
| | Genotyping Techniques | 2 | 2018 | 69 | 0.160 |
Why?
| | Tremor | 2 | 2018 | 98 | 0.160 |
Why?
| | Respiratory Sounds | 1 | 2021 | 105 | 0.160 |
Why?
| | Pregnancy, Twin | 1 | 2020 | 19 | 0.160 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 47 | 0.160 |
Why?
| | Cohort Studies | 7 | 2026 | 5960 | 0.160 |
Why?
| | Inpatients | 2 | 2022 | 545 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2025 | 365 | 0.160 |
Why?
| | Aged, 80 and over | 7 | 2026 | 8265 | 0.160 |
Why?
| | Hysterectomy | 1 | 2021 | 137 | 0.150 |
Why?
| | Analgesics, Opioid | 2 | 2026 | 1143 | 0.150 |
Why?
| | Mental Health | 2 | 2024 | 790 | 0.150 |
Why?
| | Hospitalization | 5 | 2021 | 2433 | 0.150 |
Why?
| | Medicaid | 2 | 2021 | 461 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2020 | 88 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 52 | 0.150 |
Why?
| | Friends | 1 | 2019 | 56 | 0.150 |
Why?
| | Duffy Blood-Group System | 1 | 2019 | 5 | 0.150 |
Why?
| | History, 21st Century | 1 | 2020 | 219 | 0.150 |
Why?
| | Florida | 4 | 2019 | 117 | 0.150 |
Why?
| | Exotoxins | 1 | 2019 | 16 | 0.150 |
Why?
| | Siblings | 2 | 2013 | 195 | 0.150 |
Why?
| | Janus Kinase 2 | 1 | 2019 | 29 | 0.150 |
Why?
| | Orbital Cellulitis | 1 | 2019 | 17 | 0.150 |
Why?
| | Dermatitis, Atopic | 1 | 2022 | 321 | 0.150 |
Why?
| | Cone Opsins | 1 | 2018 | 2 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 36 | 0.150 |
Why?
| | Hemolysin Proteins | 1 | 2019 | 36 | 0.140 |
Why?
| | Laryngismus | 1 | 2018 | 10 | 0.140 |
Why?
| | History, 20th Century | 1 | 2020 | 325 | 0.140 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2018 | 20 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2022 | 281 | 0.140 |
Why?
| | Antimicrobial Stewardship | 1 | 2021 | 129 | 0.140 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 202 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2019 | 109 | 0.140 |
Why?
| | Chronic Pain | 1 | 2023 | 290 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2020 | 243 | 0.140 |
Why?
| | Lasers | 1 | 2018 | 132 | 0.140 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2019 | 90 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1135 | 0.140 |
Why?
| | Pregnancy Trimester, Second | 1 | 2018 | 82 | 0.140 |
Why?
| | Europe | 2 | 2022 | 412 | 0.140 |
Why?
| | Laparoscopy | 1 | 2022 | 475 | 0.140 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2925 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5408 | 0.130 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2020 | 182 | 0.130 |
Why?
| | Opioid-Related Disorders | 1 | 2026 | 600 | 0.130 |
Why?
| | Audiometry, Pure-Tone | 1 | 2017 | 33 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2022 | 384 | 0.130 |
Why?
| | Neuromuscular Agents | 1 | 2018 | 45 | 0.130 |
Why?
| | Botulinum Toxins, Type A | 1 | 2018 | 58 | 0.130 |
Why?
| | Mouth | 1 | 2017 | 88 | 0.130 |
Why?
| | Synaptic Transmission | 1 | 2019 | 290 | 0.130 |
Why?
| | Event-Related Potentials, P300 | 1 | 2016 | 15 | 0.130 |
Why?
| | Databases, Factual | 4 | 2025 | 1486 | 0.130 |
Why?
| | Heart Rate | 1 | 2021 | 855 | 0.130 |
Why?
| | Endophenotypes | 1 | 2016 | 21 | 0.130 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 310 | 0.130 |
Why?
| | Neurocognitive Disorders | 1 | 2017 | 33 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 557 | 0.130 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 161 | 0.120 |
Why?
| | Case-Control Studies | 4 | 2017 | 3604 | 0.120 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 377 | 0.120 |
Why?
| | Parenting | 1 | 2020 | 318 | 0.120 |
Why?
| | Patient Discharge | 2 | 2022 | 983 | 0.120 |
Why?
| | Patient Readmission | 1 | 2022 | 758 | 0.120 |
Why?
| | Postpartum Period | 1 | 2019 | 365 | 0.120 |
Why?
| | United States | 8 | 2026 | 15966 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 616 | 0.120 |
Why?
| | Phylogeny | 1 | 2021 | 1016 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 612 | 0.120 |
Why?
| | Regression Analysis | 3 | 2021 | 1003 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2022 | 851 | 0.120 |
Why?
| | Retina | 1 | 2018 | 324 | 0.120 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 151 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 442 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 183 | 0.120 |
Why?
| | Telephone | 1 | 2016 | 175 | 0.120 |
Why?
| | Pityriasis Rubra Pilaris | 1 | 2015 | 1 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 600 | 0.110 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2020 | 370 | 0.110 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 22 | 0.110 |
Why?
| | Guanylate Cyclase | 1 | 2015 | 39 | 0.110 |
Why?
| | Curriculum | 1 | 2022 | 1059 | 0.110 |
Why?
| | Genetic Research | 1 | 2015 | 17 | 0.110 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1985 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2015 | 132 | 0.110 |
Why?
| | Comprehension | 1 | 2016 | 180 | 0.110 |
Why?
| | Staphylococcus aureus | 1 | 2019 | 455 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 388 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2019 | 501 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 197 | 0.100 |
Why?
| | Comorbidity | 2 | 2019 | 1658 | 0.100 |
Why?
| | Masculinity | 1 | 2013 | 11 | 0.100 |
Why?
| | Asthma | 1 | 2026 | 1767 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2024 | 1166 | 0.100 |
Why?
| | Antisocial Personality Disorder | 1 | 2015 | 121 | 0.100 |
Why?
| | Genetic Testing | 1 | 2017 | 478 | 0.100 |
Why?
| | Genetic Fitness | 1 | 2014 | 59 | 0.100 |
Why?
| | Moral Obligations | 1 | 2013 | 15 | 0.100 |
Why?
| | Prescription Drug Diversion | 1 | 2013 | 13 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6429 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2022 | 1152 | 0.100 |
Why?
| | Biopsy, Needle | 1 | 2014 | 183 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2015 | 146 | 0.100 |
Why?
| | Administration, Topical | 1 | 2013 | 150 | 0.100 |
Why?
| | Liability, Legal | 1 | 2013 | 43 | 0.100 |
Why?
| | Africa | 1 | 2013 | 116 | 0.100 |
Why?
| | Interpersonal Relations | 2 | 2008 | 400 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 321 | 0.100 |
Why?
| | Biopsy | 1 | 2016 | 1075 | 0.100 |
Why?
| | Child | 10 | 2026 | 22633 | 0.100 |
Why?
| | Outpatients | 1 | 2016 | 442 | 0.100 |
Why?
| | Adolescent Development | 1 | 2013 | 72 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2019 | 869 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 969 | 0.090 |
Why?
| | Anxiety Disorders | 1 | 2016 | 373 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2452 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2019 | 955 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 1 | 2015 | 420 | 0.090 |
Why?
| | Choice Behavior | 1 | 2013 | 177 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2022 | 11679 | 0.090 |
Why?
| | Parathyroid Glands | 1 | 2011 | 11 | 0.090 |
Why?
| | Monitoring, Physiologic | 2 | 2025 | 289 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 640 | 0.090 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 628 | 0.090 |
Why?
| | Life Style | 2 | 2021 | 479 | 0.080 |
Why?
| | Virginia | 2 | 2009 | 55 | 0.080 |
Why?
| | NF-kappa B | 1 | 2015 | 661 | 0.080 |
Why?
| | Population Density | 1 | 2011 | 101 | 0.080 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2011 | 69 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 168 | 0.080 |
Why?
| | Anthropometry | 2 | 2024 | 200 | 0.080 |
Why?
| | Microbiota | 1 | 2017 | 781 | 0.070 |
Why?
| | Military Personnel | 1 | 2017 | 741 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2013 | 491 | 0.070 |
Why?
| | Decision Making | 1 | 2016 | 975 | 0.070 |
Why?
| | International Classification of Diseases | 2 | 2019 | 147 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 484 | 0.070 |
Why?
| | Risk | 3 | 2019 | 911 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2947 | 0.070 |
Why?
| | Child, Preschool | 5 | 2026 | 11787 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2016 | 893 | 0.070 |
Why?
| | Prevalence | 1 | 2015 | 2834 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2009 | 248 | 0.070 |
Why?
| | Thinking | 1 | 2008 | 66 | 0.060 |
Why?
| | Personality Inventory | 1 | 2007 | 134 | 0.060 |
Why?
| | Diseases in Twins | 1 | 2007 | 115 | 0.060 |
Why?
| | Health Status | 2 | 2024 | 836 | 0.060 |
Why?
| | Incidence | 2 | 2025 | 2879 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2018 | 1306 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2011 | 780 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1169 | 0.060 |
Why?
| | Gestational Age | 2 | 2019 | 975 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1325 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2006 | 67 | 0.060 |
Why?
| | Length of Stay | 2 | 2022 | 1337 | 0.060 |
Why?
| | Personality Assessment | 1 | 2005 | 79 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2608 | 0.060 |
Why?
| | Deglutition | 1 | 2025 | 72 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 541 | 0.060 |
Why?
| | Transcriptome | 2 | 2022 | 1045 | 0.060 |
Why?
| | Ectodermal Dysplasia | 1 | 2005 | 19 | 0.060 |
Why?
| | Norway | 1 | 2024 | 45 | 0.050 |
Why?
| | Connexin 43 | 1 | 2005 | 36 | 0.050 |
Why?
| | Australia | 1 | 2005 | 286 | 0.050 |
Why?
| | Social Isolation | 1 | 2005 | 72 | 0.050 |
Why?
| | Connexins | 1 | 2005 | 56 | 0.050 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2310 | 0.050 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 17 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2024 | 49 | 0.050 |
Why?
| | Mastectomy | 1 | 2025 | 162 | 0.050 |
Why?
| | Propensity Score | 1 | 2026 | 367 | 0.050 |
Why?
| | Mammaplasty | 1 | 2025 | 104 | 0.050 |
Why?
| | Ureteroscopy | 1 | 2022 | 16 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 285 | 0.050 |
Why?
| | Intubation, Intratracheal | 1 | 2026 | 320 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 123 | 0.050 |
Why?
| | Pruritus | 1 | 2022 | 59 | 0.050 |
Why?
| | Social Behavior | 2 | 2019 | 288 | 0.050 |
Why?
| | Paralysis | 1 | 2022 | 67 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2024 | 252 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2025 | 592 | 0.040 |
Why?
| | Upper Extremity | 1 | 2022 | 112 | 0.040 |
Why?
| | Hand | 1 | 2022 | 161 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2026 | 1030 | 0.040 |
Why?
| | Infant | 3 | 2020 | 10034 | 0.040 |
Why?
| | Gene Expression | 1 | 2006 | 1490 | 0.040 |
Why?
| | Tibia | 1 | 2022 | 176 | 0.040 |
Why?
| | Brain | 3 | 2023 | 2933 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 375 | 0.040 |
Why?
| | Animals | 6 | 2019 | 38058 | 0.040 |
Why?
| | Bone Density | 1 | 2024 | 482 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 4089 | 0.040 |
Why?
| | Social Sciences | 1 | 2019 | 8 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 976 | 0.040 |
Why?
| | Nebraska | 1 | 2019 | 21 | 0.040 |
Why?
| | Arkansas | 1 | 2019 | 21 | 0.040 |
Why?
| | Iowa | 1 | 2019 | 32 | 0.040 |
Why?
| | Receptors, Thrombopoietin | 1 | 2019 | 6 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2168 | 0.040 |
Why?
| | Maryland | 1 | 2019 | 66 | 0.040 |
Why?
| | Wisconsin | 1 | 2019 | 99 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1886 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 31 | 0.040 |
Why?
| | New York | 1 | 2019 | 125 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 38 | 0.040 |
Why?
| | Infrared Rays | 1 | 2018 | 27 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2019 | 90 | 0.040 |
Why?
| | Macaca fascicularis | 1 | 2018 | 71 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 54 | 0.040 |
Why?
| | Biometry | 1 | 2018 | 68 | 0.040 |
Why?
| | Morbidity | 1 | 2019 | 323 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 551 | 0.040 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 69 | 0.030 |
Why?
| | Laryngeal Muscles | 1 | 2018 | 10 | 0.030 |
Why?
| | Voice Quality | 1 | 2018 | 23 | 0.030 |
Why?
| | Cefotaxime | 1 | 2017 | 3 | 0.030 |
Why?
| | Counseling | 1 | 2021 | 408 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 304 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 403 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1671 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 386 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 141 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2024 | 621 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 529 | 0.030 |
Why?
| | Hospitals | 1 | 2022 | 730 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1030 | 0.030 |
Why?
| | Contactins | 1 | 2016 | 2 | 0.030 |
Why?
| | Peer Group | 1 | 2019 | 257 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 836 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 1075 | 0.030 |
Why?
| | Saccades | 1 | 2016 | 45 | 0.030 |
Why?
| | Linear Models | 2 | 2012 | 854 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 476 | 0.030 |
Why?
| | Reaction Time | 1 | 2018 | 438 | 0.030 |
Why?
| | Mice | 3 | 2019 | 18339 | 0.030 |
Why?
| | Mothers | 1 | 2022 | 775 | 0.030 |
Why?
| | Alcohol Abstinence | 1 | 2015 | 13 | 0.030 |
Why?
| | Cell Survival | 1 | 2019 | 1098 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1382 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5868 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 380 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2016 | 198 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1463 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1539 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 293 | 0.030 |
Why?
| | Finland | 1 | 2014 | 79 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2117 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 113 | 0.030 |
Why?
| | Genetic Phenomena | 1 | 2013 | 6 | 0.030 |
Why?
| | Synapses | 1 | 2017 | 439 | 0.030 |
Why?
| | Electroencephalography | 1 | 2016 | 532 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 62 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 62 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2112 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2015 | 160 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 383 | 0.020 |
Why?
| | Risk-Taking | 1 | 2015 | 328 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 105 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3121 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3333 | 0.020 |
Why?
| | Parathyroidectomy | 1 | 2011 | 9 | 0.020 |
Why?
| | Chromatin | 1 | 2015 | 561 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4154 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1821 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 43 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3540 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2011 | 91 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4282 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3671 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1114 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 84 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1907 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4564 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2022 | 2919 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 260 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4271 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 281 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7173 | 0.020 |
Why?
| | Trachea | 1 | 2011 | 261 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4109 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1134 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1053 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4557 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 2050 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2011 | 652 | 0.020 |
Why?
| | Connexin 26 | 1 | 2005 | 9 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 76 | 0.010 |
Why?
| | Data Collection | 1 | 2008 | 633 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2005 | 121 | 0.010 |
Why?
| | Motor Cortex | 1 | 2005 | 65 | 0.010 |
Why?
| | Functional Laterality | 1 | 2005 | 241 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 406 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2008 | 901 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2005 | 328 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1054 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5226 | 0.010 |
Why?
| | Pain | 1 | 2005 | 779 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3863 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|